Skip to main content
. Author manuscript; available in PMC: 2019 Feb 27.
Published in final edited form as: Clin Cancer Res. 2017 Sep 5;23(22):6823–6832. doi: 10.1158/1078-0432.CCR-17-1260

Table 1.

Patient and tumor characteristics (n = 16)

Median age (range) 57 (40–77) years
Menopausal status
 Premenopausal 4 (25%)
 Postmenopausal 12 (75%)
Histology
 Ductal 8 (50%)
 Lobular 8 (50%)
Histologic grade
 1 3 (19%)
 2 11 (69%)
 3 2 (12%)
Clinical T and N stage
 T2N0 6 (38%)
 T2N1 3 (19%)
 T3N0 2 (13%)
 T3N1 4 (25%)
 Unknown 1 (6%)
PIK3CA mutation
 E542K/V 2 (13%)
 E545K 3 (19%)
 H1047L/R 8 (50%)
 E418G, C420R 1 (6%)
 Del/ins 2 (13%)